tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Catalyst Pharmaceuticals reports Q3 EPS 68c, consensus 54c
PremiumThe FlyCatalyst Pharmaceuticals reports Q3 EPS 68c, consensus 54c
2M ago
Catalyst Pharma Reports Strong Q3 2025 Financial Results
Premium
Company Announcements
Catalyst Pharma Reports Strong Q3 2025 Financial Results
2M ago
Is CPRX a Buy, Before Earnings?
Premium
Pre-Earnings
Is CPRX a Buy, Before Earnings?
2M ago
Catalyst Pharma Settles Patent Dispute with Lupin
PremiumCompany AnnouncementsCatalyst Pharma Settles Patent Dispute with Lupin
4M ago
Catalyst Pharmaceuticals announces settlement of FIRDAPSE patent litigation
Premium
The Fly
Catalyst Pharmaceuticals announces settlement of FIRDAPSE patent litigation
4M ago
Catalyst Pharmaceuticals Reports Strong Q2 2025 Earnings
Premium
Company Announcements
Catalyst Pharmaceuticals Reports Strong Q2 2025 Earnings
5M ago
Catalyst announces NCCN Guidelines for SCLC include new additions
PremiumThe FlyCatalyst announces NCCN Guidelines for SCLC include new additions
5M ago
Catalyst Pharma Appoints Dr. Curran to Board
Premium
Company Announcements
Catalyst Pharma Appoints Dr. Curran to Board
5M ago
Catalyst Pharmaceuticals appoints Curran to its board of directors
Premium
The Fly
Catalyst Pharmaceuticals appoints Curran to its board of directors
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100